Yi H - Search Results

1

ALK-positive large B-cell lymphoma: a clinicopathological and molecular characteristics analysis of seven cases.

Wang X, Yi H, Liu Q, Guo T, Li A, Ouyang B, Li Y, Zhang Y, Xu H, Dong L, Wang X, Wang C. Wang X, et al. Among authors: yi h. Pathology. 2024 Aug 13:S0031-3025(24)00190-9. doi: 10.1016/j.pathol.2024.05.014. Online ahead of print. Pathology. 2024. PMID: 39237383

2

B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.

Zhou L, Gu B, Shen X, Binshen O, Dong L, Zhou J, Yi H, Wang C. Zhou L, et al. Among authors: yi h. Pathol Int. 2021 Mar;71(3):183-190. doi: 10.1111/pin.13067. Epub 2021 Jan 27. Pathol Int. 2021. PMID: 33503299

3

De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients.

Fan Y, Binshen O, Zhang Z, Yi H, Zhang W, Liu Q, Liu Y, Dong L, Wang C. Fan Y, et al. Among authors: yi h. Ann Diagn Pathol. 2022 Jun;58:151886. doi: 10.1016/j.anndiagpath.2021.151886. Epub 2022 Feb 4. Ann Diagn Pathol. 2022. PMID: 35255429

4

Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement.

Zhang Y, Li A, Li Y, Ouyang B, Wang X, Zhang L, Xu H, Gu Y, Lu X, Dong L, Yi H, Wang C. Zhang Y, et al. Among authors: yi h. Am J Surg Pathol. 2024 Nov 1;48(11):1341-1348. doi: 10.1097/PAS.0000000000002301. Epub 2024 Aug 22. Am J Surg Pathol. 2024. PMID: 39172106

5

[Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements].

Shen X, Zhou LT, Li AQ, Yi HM, Ouyang BS, Xu HM, Xie JL, Gu YJ, Zhang L, Dong L. Shen X, et al. Among authors: yi hm. Zhonghua Bing Li Xue Za Zhi. 2022 Feb 8;51(2):120-125. doi: 10.3760/cma.j.cn112151-20210826-00604. Zhonghua Bing Li Xue Za Zhi. 2022. PMID: 35152630 Chinese.

6

Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma.

Xie J, Shen X, Shi Q, Yi H, Ouyang B, Zhang Z, Gu Y, Dong L. Xie J, et al. Among authors: yi h. Hematol Oncol. 2022 Dec;40(5):885-893. doi: 10.1002/hon.3073. Epub 2022 Sep 10. Hematol Oncol. 2022. PMID: 36053490

7

Clinicopathological and molecular features of indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.

Yi H, Li A, Ouyang B, Da Q, Dong L, Liu Y, Xu H, Zhang X, Zhang W, Jin X, Gu Y, Wang Y, Liu Z, Wang C. Yi H, et al. Histopathology. 2023 Mar;82(4):567-575. doi: 10.1111/his.14850. Epub 2023 Jan 18. Histopathology. 2023. PMID: 36494712

8

EBV-Associated Smooth Muscle Tumors With Autoimmune Hemolytic Anemia and Hepatitis B Infection: Report of a Previously Undescribed Neoplasm With Review.

Zheng Q, Wang C, Zhang Y, Xu H, Yuan F, Yi H. Zheng Q, et al. Among authors: yi h. Int J Surg Pathol. 2024 Sep;32(6):1197-1203. doi: 10.1177/10668969231217631. Epub 2024 Jan 2. Int J Surg Pathol. 2024. PMID: 38166493 Review.

9

The genetic landscape of histologically transformed marginal zone lymphomas.

Li A, Yi H, Deng S, Ruan M, Xu P, Huo Y, Lu H, Shen X, Ouyang B, Cai M, Xu H, Wang Z, Zhang L, Zhu L, Peng Q, Gu Y, Xie J, Wang Y, Dong L, Liu Z, Wang C. Li A, et al. Among authors: yi h. Cancer. 2024 Apr 15;130(8):1246-1256. doi: 10.1002/cncr.35072. Epub 2023 Nov 8. Cancer. 2024. PMID: 37941429

10

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.

Wang Y, Shi Q, Shi ZY, Tian S, Zhang MC, Shen R, Fu D, Dong L, Yi HM, Ouyang BS, Mu RJ, Cheng S, Wang L, Xu PP, Zhao WL. Wang Y, et al. Blood Adv. 2024 Apr 9;8(7):1587-1599. doi: 10.1182/bloodadvances.2023011425. Blood Adv. 2024. PMID: 38170757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,391 results

Search Page

Filters